Webinar Wednesday, June 27 | Discover how Lund University is using digital pathology to support their TMA studies for biomarker discovery with Xplore 1
Xplore: Learn how digital pathology is supporting research and discovery for Lund University
When: Weds., June 27, 2018 6:00 AM – 7:00 AM PDT
Join Carina Forsare from Lund University to discover how they are using digital pathology to support their TMA studies for biomarker discovery with Philips: Xplore1. Tissue Microarrays (TMA’s) have been validated as useful tools for the evaluation of various biomarkers, especially in oncology specimens. Managing TMA’s with digital and computational pathology has the potential to speed up your research and biomarker discovery.
During this webinar you will learn how Xplore can be used to manage Tissue Microarrays, whole slide images, and can support discovery by connecting your virtual slides with your image analysis vendor. We will also be demonstrating the latest updates to Xplore, including new compliance features to support 21 CFR Part 11 and GLP approved studies.
Philips Digital Pathology Solutions aim to drive improvements in cancer research, biomarker investigations, pre-clinical studies, clinical trials and companion diagnostics that can be translated into clinical practice, and guide pathologists in therapeutic decision making and delivery of precision medicine.
About our speakers:
Carina Forsare, from Lund University is a biomedical scientist with a PhD within the field of breast cancer, with special interest in investigating prognostic and predictive markers to find ways to improve the use of established factors. Carina’s background both in pathology and oncology is dating back more than 20 years. Carina is well familiar with IHC, TMA, and evaluations, but also statistics (survival analysis) and molecular techniques. Since her PhD she has worked with circulating tumor cells in breast cancer.
Mike Stewart is the Product Manager within Philips Digital Pathology for their life-sciences platform, ‘Xplore’. He has experience of working with Academic Medical Centers, Biotech, CRO and Pharma companies worldwide, delivering innovative solutions for a range of real-world problems using digital pathology. Mike has worked in the field of digital pathology since 2011, and holds a first class honors degree in Business & IT from The Queen’s University of Belfast.
1Xplore is not intended for diagnostic, monitoring or therapeutic purposes or in any other manner for regular medical practice.
